BridgeBio Oncology Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2023 | $396.5K | $332.9K | $250.0K |
| Mar 2024 | $5.5M | $187.5M | $1.8M |
| Jun 2024 | $5.6M | $189.9M | $1.8M |
| Sep 2024 | $5.6M | $192.3M | $20.4M |
| Dec 2024 | $19.6M | $164.3M | $30.9M |
| Mar 2025 | $7.4M | $195.7M | $26.3M |
| Jun 2025 | $8.1M | $197.4M | $31.7M |
| Sep 2025 | $38.1M | $484.8M | $408.7M |
| Dec 2025 | $37.3M | $448.4M | $373.7M |
| Mar 2026 | $45.4M | $417.6M | $52.7M |
| Jun 2026 | $53.6M | $376.7M | $54.1M |